Literature DB >> 12684270

Differences in troglitazone action on glucose metabolism in freshly isolated vs long-term incubated rat skeletal muscle.

Florian Gras1, Barbara Brunmair, Michael Roden, Werner Waldhäusl, Clemens Fürnsinn.   

Abstract

1. Exposure of isolated skeletal muscle to troglitazone has resulted in inconsistent findings ranging from inhibition to stimulation of fuel oxidation and the glycogenic pathway. To better understand such variation in outcome, the present study used isolated rat soleus muscle strips to examine the interdependent influences of prolonged maintenance in vitro and of troglitazone exposure. 2. If freshly isolated muscle strips were exposed to troglitazone (1 micro mol l(-1)) for 24 h, glucose oxidation was markedly reduced (-26+/-1%, P<0.0001), whereas glycogen synthesis remained unaffected (+9+/-7%, n.s.). 3. In contrast, extended exposure to troglitazone for 72 h increased both glucose oxidation (+65+/-28%, P<0.05) and glycogen synthesis (+46+/-11%, P<0.005), and a similar stimulatory effect was also observed in muscles exposed to troglitazone only during the last 24 h of their 72 h preincubation period (glucose oxidation: +61+/-15%, P<0.001; glycogen synthesis: +43+/-15%, P<0.01). 4. Troglitazone thus stimulated glucose utilization in long-term incubated muscle independent of the duration of exposure (24 or 72 h), whereas it inhibited glucose utilization in freshly isolated muscle. 5. The observed differences in troglitazone action on freshly isolated vs long-term incubated muscle suggest that findings on muscle tissue subject to prolonged maintenance in vitro cannot be extrapolated to native muscle in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684270      PMCID: PMC1573759          DOI: 10.1038/sj.bjp.0705162

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Troglitazone regulation of glucose metabolism in human skeletal muscle cultures from obese type II diabetic subjects.

Authors:  K S Park; T P Ciaraldi; L Abrams-Carter; S Mudaliar; S E Nikoulina; R R Henry
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

Review 2.  PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.

Authors:  B M Spiegelman
Journal:  Diabetes       Date:  1998-04       Impact factor: 9.461

3.  Long term culture of rat soleus muscle in vitro. Its effects on glucose utilization and insulin sensitivity.

Authors:  P B Stace; D R Marchington; A L Kerbey; P J Randle
Journal:  FEBS Lett       Date:  1990-10-29       Impact factor: 4.124

4.  Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

Authors:  S E Inzucchi; D G Maggs; G R Spollett; S L Page; F S Rife; V Walton; G I Shulman
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

5.  Insulin resistance of denervated rat muscle: a model for impaired receptor-function coupling.

Authors:  C F Burant; S K Lemmon; M K Treutelaar; M G Buse
Journal:  Am J Physiol       Date:  1984-11

6.  Failure of GLP-1(7-36)amide to affect glycogenesis in rat skeletal muscle.

Authors:  C Fürnsinn; K Ebner; W Waldhäusl
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

7.  Actions of novel antidiabetic thiazolidinedione, T-174, in animal models of non-insulin-dependent diabetes mellitus (NIDDM) and in cultured muscle cells.

Authors:  K Arakawa; T Ishihara; M Aoto; M Inamasu; A Saito; K Ikezawa
Journal:  Br J Pharmacol       Date:  1998-10       Impact factor: 8.739

8.  Regulation of glucose transport by pioglitazone in cultured muscle cells.

Authors:  I M el-Kebbi; S Roser; R J Pollet
Journal:  Metabolism       Date:  1994-08       Impact factor: 8.694

9.  Regulation of glucose transport in cultured muscle cells by novel hypoglycemic agents.

Authors:  T P Ciaraldi; K Huber-Knudsen; M Hickman; J M Olefsky
Journal:  Metabolism       Date:  1995-08       Impact factor: 8.694

10.  Insulin resistance in soleus muscle from obese Zucker rats. Involvement of several defective sites.

Authors:  M Crettaz; M Prentki; D Zaninetti; B Jeanrenaud
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.